
Twenty Years of The State Pharmacopoeia of Ukraine: The Experience of Establishing the First National Pharmacopoeia in The Post-Soviet Area
Author(s) -
Oleksandr Grizodoub
Publication year - 2021
Publication title -
ssp modern pharmacy and medicine
Language(s) - English
Resource type - Journals
ISSN - 2733-368X
DOI - 10.53933/sspmpm.v1i2.22
Subject(s) - pharmacopoeia , medicine , population , traditional medicine , state (computer science) , law , political science , environmental health , alternative medicine , mathematics , algorithm , pathology
The quality and life expectancy of the population depends on the level of access to modern, high-quality, effective and evidence-based medical and pharmaceutical care. These types of care play a significant role in the pharmacotherapy of cardiovascular disease (CVD), which is one of the main medical, biological and socio-economic problems of society. CVDs cause 67% of all deaths in Ukraine. For comparison: in France and Japan, this component in the structure of mortality is 29%, in the United States - 31%. Heart attacks are one of the main nosologies that cause high mortality from COVID. The 1st October, 2021 marks 20 years since the introduction of the State Pharmacopoeia of Ukraine. The purpose of the study was to experience of creating the first national pharmacopoeia in the post-Soviet space. Ukraine, the first in the post-Soviet space, managed to create its own State Pharmacopoeia, which is fully harmonized with the European Pharmacopoeia and takes into account national specifics. The State Pharmacopoeia of Ukraine relies on its own National system of pharmacopoeial standard samples and pharmacopoeial program of professional testing of control laboratories as feedback from users. The State Pharmacopoeia of Ukraine is not funded by the state, and the Pharmacopoeia Center is a completely self-supporting structure. In general, the State Pharmacopoeia of Ukraine can be considered the best National Pharmacopoeia in the post-Soviet space.